Boundless BioBOLD
那斯達克 · USD
2.78
-0.01
(-0.18%)
收盤 08/14 03:59 (UTC+8)
08/14 03:59 (UTC+8)
Boundless BioBOLD
2.78
-0.01
(-0.18%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 24,384 | 14,475 | 14,002 | 15,148 | 17,061 | 17,341 | - | 18,715 | 19,391 | - |
研發費用 | 13,973 | 9,734 | 9,817 | 10,673 | 12,217 | 12,138 | 13,314 | 14,089 | 14,735 | 13,129 |
推銷及管理費用 | 10,411 | 4,741 | 4,185 | 4,475 | 4,844 | 5,203 | 4,964 | 4,626 | 4,656 | 3,754 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -24,384 | -14,475 | -14,002 | -15,148 | -17,061 | -17,341 | -18,278 | -18,715 | -19,391 | -16,883 |
其他收入及費用 | - | 920 | 1,117 | 1,269 | 1,386 | 1,583 | 1,830 | 2,206 | 2,415 | 1,453 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -23,693 | -13,555 | -12,885 | -13,879 | -15,675 | -15,758 | -16,448 | -16,509 | -16,976 | -15,430 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -23,693 | -13,555 | -12,885 | -13,879 | -15,675 | -15,758 | -16,448 | -16,509 | -16,976 | -15,430 |
基本每股稅後盈餘(元) | -1.06 | -0.60 | -0.58 | -0.62 | -0.70 | -0.71 | 9.93 | -0.74 | -0.77 | -12.27 |
稀釋每股稅後盈餘(元) | -1.06 | -0.60 | -0.57 | -0.62 | -0.70 | -0.71 | -0.63 | -0.44 | 9.49 | -12.27 |
基本平均股數(千股) | 22450.00 | 22407.00 | 22399.00 | 22386.00 | 22356.00 | 22300.00 | 22401.00 | 22254.00 | 22023.00 | 1258.00 |
稀釋平均股數(千股) | 22450.00 | 22407.00 | 22399.00 | 22386.00 | 22356.00 | 22300.00 | 22401.00 | 22254.00 | 22023.00 | 1258.00 |
還原基本每股稅後盈餘(元) | -1.06 | -0.60 | -0.58 | -0.62 | -0.70 | -0.71 | 9.93 | -0.74 | -0.77 | -12.27 |
還原稀釋每股稅後盈餘(元) | -1.06 | -0.60 | -0.57 | -0.62 | -0.70 | -0.71 | -0.63 | -0.44 | 9.49 | -12.27 |
還原基本平均股數(千股) | 22,450 | 22,407 | 22,399 | 22,386 | 22,356 | 22,300 | 22,401 | 22,254 | 22,023 | 1,258 |
還原稀釋平均股數(千股) | 22,450 | 22,407 | 22,399 | 22,386 | 22,356 | 22,300 | 22,401 | 22,254 | 22,023 | 1,258 |
EBITDA(千元) | -22,436 | -13,604 | -13,083 | -14,146 | -16,050 | -16,257 | -17,204 | -17,574 | -18,415 | -16,139 |